Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Holding(s) in Company

30th Oct 2007 17:08

Ark Therapeutics Group PLC30 October 2007 TR-1: NOTIFICATION OF MAJOR INTERESTS IN SHARES (1). Identity of the issuer or the underlying issuer of existing shares to whichvoting rights are attached: ARK THERAPEUTICS GROUP PLC 2. Reason for the notification (please state Yes/No): ( ) An acquisition or disposal of voting rights: ( X ) An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached: ( ) An event changing the breakdown of voting rights: ( ) Other (please specify) : ( ) 3. Full name of person(s) subject to the notification obligation: LEGAL & GENERAL GROUP PLC (L&G) 4. Full name of shareholder(s) (if different from 3.): LEGAL & GENERAL ASSURANCE (PENSIONS MANAGEMENT) LIMITED (PMC) 5. Date of the transaction and date on which the threshold is crossed or reachedif different): 17 OCTOBER 2007 6. Date on which issuer notified: 30 OCTOBER 2007 7. Threshold(s) that is/are crossed or reached: FROM 3% TO 4% (L&G) 8. Notified details: A: Voting rights attached to shares Class/type of shares: ORD 1P Situation previous to the triggering transaction: Number of shares: 6,443,402 Number of voting Rights: 6,443,402 Resulting situation after the triggering transaction: Number of shares: Direct: 6,851,468 Number of voting Rights: Direct: 6,851,468 Indirect: % of voting rights: Direct: 4.11% Indirect: B: Financial Instruments Resulting situation after the triggering transaction: Type of financial instrument: Expiration Date: Exercise/Conversion Period/ Date: Number of voting rights that may be acquired if the instrument is exercised/converted: % of voting rights: Total (A+B) Number of voting rights: 6,851,468 % of voting rights: 4.11% 9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: Legal & General Group Plc (Direct and Indirect) (Group) Legal & General Investment Management (Holdings) Limited (LGIMH) (Direct and Indirect) Legal & General Investment Management Limited (Indirect) (LGIM) Legal & General Group Plc (Direct) (L&G) (6,851,468 - 4.11% = LGAS, LGPL & PMC) Legal & General Investment Management (Holdings) Limited Legal & General Insurance Holdings Limited(Direct) (LGIMHD) (6,027,019 - 3.62% = PMC) (Direct)(LGIH) Legal & General Assurance (Pensions Management) Limited Legal & General Assurance Society Limited (PMC)(6,027,019 - 3.62% = PMC) (LGAS & LGPL) Legal & General Pensions Limited (Direct) (LGPL) Proxy Voting: 10. Name of the proxy holder: N/A 11. Number of voting rights proxy holder will cease to hold: N/A 12. Date on which proxy holder will cease to hold voting rights: N/A 13. Additional information: NOTIFICATION USING THE TOTAL VOTING RIGHTS FIGURE OF 166,302,680 14. Contact name: HELEN LEWIS (LGIM) 15. Contact telephone number: 020 3124 3851 16. Contact name and telephone at issuer: NICK PLUMMERCompany SecretaryArk Therapeutics Group plc 020 7388 7722 30 October 2007 This information is provided by RNS The company news service from the London Stock Exchange

Related Shares:

PVG.LLegal & General
FTSE 100 Latest
Value8,417.34
Change2.09